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Objective: To investigate the cellular uptake of evodiamine and rutaecarpine in a microemulsion 
in comparison with aqueous suspensions and tinctures.
Materials and methods: A microemulsion was prepared using the dropwise addition 
method. Mouse skin fibroblasts were cultured in vitro to investigate the optimal conditions 
for evodiamine and rutaecarpine uptake with different drug concentrations and administration 
times. Under optimal conditions, the cellular uptake of microemulsified drugs was assayed 
and compared to tinctures and aqueous suspensions. Rhodamine B labeling and laser scanning 
confocal microscopy (LSCM) were used to explore the distribution of fluorochrome transferred 
with the microemulsion in fibroblasts. Cellular morphology was also investigated, using optical 
microscopy to evaluate microemulsion-induced cellular toxicity.
Results: The maximum cellular drug uptake amounts were obtained with a 20% concentration 
(v/v) of microemulsion and an 8 hour administration time. Drug uptake by mouse skin fibroblasts 
was lowest when the drugs were loaded in microemulsion. After incubation with rhodamine 
B-labeled microemulsion for 8 hours, the highest fluorescence intensity was achieved, and the 
fluorochrome was primarily distributed in the cytochylema. No obvious cellular morphologic 
changes were observed with the administration of either the microemulsion or the aqueous 
suspension; for the tincture group, however, massive cellular necrocytosis was observed.
Conclusion: The lower cellular uptake with microemulsion may be due to the fact that 
most of the drug loaded in the microemulsion vehicle was transported via the intercellular 
space, while a small quantity of free drug (released from the vehicle) was ingested through 
transmembrane transport. Mouse skin fibroblasts rarely endocytosed evodiamine and rutaecarpine 
with a microemulsion as the vehicle. The microemulsion had no obvious effect on cellular 
morphology, suggesting there is little or no cellular toxicity associated with the administration 
of microemulsion on mouse skin fibroblasts.
Keywords: mouse skin fibroblasts, evodiamine, rutaecarpine, microemulsion, cellular uptake, 
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Introduction
Evodiamine (Evo) and rutaecarpine (Rut) are important bioactive alkaloids isolated 
from the Chinese medicinal herb Evodia rutaecarpa (Juss.) Benth.1–3 Evo and Rut 
have been reported to exhibit anti-inflammatory4 and anti-nociceptive5 effects. Both 
Evo and Rut have been found to strongly inhibit prostaglandin E2 synthesis from 
lipopolysaccharide-treated RAW 264.7 cells, and Evo has also been shown to inhibit 
cyclooxygenase-2 induction and NF-κB activation.6–9 However, these alkaloids are 
insoluble in water, which limits their transdermal absorption. In order to address 
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this problem, an oil-in-water (o/w) microemulsion was 
designed as a vehicle to increase the solubility of these 
compounds. The application of this novel microemulsion 
could markedly improve the transdermal absorption of 
Evo and Rut compared to that obtained using aqueous 
suspensions and tinctures.10
Microemulsions have received increasing attention in 
recent years. A microemulsion is defined as a dispersion 
consisting of oil, surfactant, cosurfactant, and an aqueous 
phase, which is an optically isotropic and thermodynamically 
stable liquid solution with a droplet diameter of 10–100 nm, 
and it can therefore serve as an effective nanomedicine 
vehicle.11 Microemulsion systems have several advantages 
over conventional formulations, such as ease of manufacturing, 
increased drug solubility, good thermodynamic stability, and 
enhanced drug permeation.12 Microemulsions provide a 
promising delivery system for either sustained or controlled 
drug release through transdermal administration,10 and these 
novel transdermal delivery systems have attained increasing 
significance in basic research. For example, microemulsions 
may affect the stratum corneum (SC) layer of the skin, leading 
to increased fluidity of the bilayer, as well as interruption of 
the aqueous channels in the SC. These effects may result in 
the enhanced transdermal permeation of drugs.13–15 However, 
very few studies have been performed on the transport 
mechanism underlying microemulsion permeation through 
the SC into the dermis.
In animal tissue, fibroblasts are the most common cells 
in connective tissue.16 Dermal fibroblasts have been used 
extensively for a wide range of cellular and molecular 
studies,17 such as those on the mechanisms underlying skin 
aging,18–20 restoration of dermal wounds,21 dermal radiation 
injury,22 and construction of tissue-engineered skins.23–25
The purpose of this study was to investigate the cellular 
uptake of evodiamine and rutaecarpine in a microemulsion, 
as compared to that in aqueous suspensions and tinctures. 
Mouse skin fibroblasts were cultured in vitro and the 
amount of cellular uptake was measured using different 
concentrations, different drug administration times, and 
different formulations (ie, microemulsion, tincture, and 
suspension). These results may aid in determining the fate 
of microemulsions during dermal penetration.
Materials and methods
Cell line
Mouse skin fibroblasts (NIH/3T3) were purchased from 
the Shanghai Institute of Biochemistry and Cell Biology 
(Shanghai, China).
Materials
Evo and Rut (98% purity, as determined by high-performance 
liquid chromatography [HPLC]) were provided by Linuo 
Biotechnology Co, Ltd (Zhengzhou, China). Ethyl 
oleate was purchased from Shanghai Yunhong Chemical 
Preparation Auxiliary Technology Co, Ltd (Shanghai, 
China). Polyethylene glycol PEG-35 castor oil (Cremophor® 
EL) was obtained from BASF (Ludwigshafen, Germany). 
Rhodamine B was obtained from Sigma-Aldrich (St Louis, 
MO). High-glucose Dulbecco’s Modified Eagle’s Medium 
(DMEM/High, Fisher Scientific Worldwide [Shanghai] Co 
Ltd, Shanghai, China), 0.25% trypsin, 0.02% ethylenedi-
aminetetraacetic acid (EDTA), fetal calf serum, and phos-
phate buffered solution (PBS) were obtained from Shanghai 
Usen Biotechnology (Shanghai, China). All other chemicals 
were obtained from Sinopharm Chemical Reagent Co Ltd 
(Shanghai, China) and were of HPLC or analytical grade.
HPLC analysis of Evo and Rut
The LC-2010 A HT Liquid Chromatograph system (Shimadzu 
Corporation, Kyoto, Japan) was used for the dialysate 
sample analysis to detect the presence of Evo and Rut and to 
determine their concentrations. The HPLC system consisted 
of a double-plunger pump (Shimadzu Corporation), an 
autosampler (Shimadzu Corporation), an online degasser 
(Shimadzu Corporation), a Diamonsil C18 reverse phase 
column (5 µm, 4.6 mm [inner diameter] × 25 cm; Dikma 
Technologies, Inc, Beijing, China), a column oven (Shimadzu 
Corporation), an ultraviolet detector (Hamamatsu Photonics, 
Hamamatsu, Japan), and a recording integrator (Shimadzu 
Corporation). The mobile phase was acetonitrile:water (43:57, 
v/v) containing 0.04% (w/v) sodium 1-octanesulfonate with 
a flow rate of 1 mL/minute. The column temperature was 
constant at 35°C and the detection wavelength was 225 nm.
Preparation of microemulsion
The microemulsion used in this study contained 0.1% 
(w/w) Evo and 0.1% (w/w) Rut and was prepared using 
Cremophor EL (33.8%, w/w) as the surfactant, PEG-400 
(11.2%, w/w) as the cosurfactant, and ethyl oleate (5.0%, 
w/w) as the oil phase. Evo and Rut were added to the ethyl 
oleate and stirred until they completely dissolved. The 
solution was then added to the mixture of Cremophor EL 
and PEG-400 and then stirred. The mixture was placed on 
a magnetic stirrer (RCT B S25; IKA, Staufen, Germany), 
at 300 r/  minute, and purified water (50%, w/w) was added 
dropwise. During this process, the appearance of the mix-
ture turned from opaque to limpid, and the final preparation 
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appeared   opalescent-white when seen through light – an 
important feature of microemulsions.
Characterization of microemulsion
The average droplet size of the microemulsion was measured 
using the NanoSight LM series26 (NanoSight Ltd, Amesbury, 
UK). The viscosity of the prepared microemulsions was 
measured using a DV-I + Digital Viscometer (Brookfield 
Engineering Laboratories Inc, Middleboro, MA), with 
the No 1 rotor set at 100 rpm. Both measurements were 
performed in triplicate, and the final values were expressed 
in terms of mean ± standard deviation. The appearance 
of the microemulsion was observed using a transmission 
electron microscope (Philips/FEI Tecnai 12, Amsterdam, 
The Netherlands). The sample was prepared with negative 
staining: the copper net was supported by Formvar film on 
a stencil plate, the microemulsion was dropped gently on 
the film, and the film was allowed to dry for approximately 
20 minutes. A drop of 0.5% uranyl acetate was then added 
to the film and allowed to dry for 10 minutes. The sample 
was then observed and the image was captured.
Cell culture
The cell line was removed from storage in liquid nitrogen 
and placed in a 37°C water bath for 1 minute. Then, 10 mL 
of fresh culture medium (DMEM/High) was added to 
the culture dish with a transfer pipette and it was mixed 
uniformly. The culture dish was placed in a CO2 incubator 
(Forma 3111; Thermo Fisher Scientific, Walther, MA) for 
24 hours (5% CO2, incubator at 37°C). Subsequently, the 
culture medium was extracted using a vacuum pump; 2 mL 
PBS was added to clean the dish and was then removed 
by the vacuum pump. Zymine solution (1 mL) was added 
and mixed, and the excess zymine solution was poured out. 
The cells in the dish were digested at 37°C for 3 minutes, 
until they floated, and 4 mL of culture medium was used 
to clean the cells. The cell suspension was distributed into 
a new culture dish and 8 mL of fresh culture medium was 
added for subcultivation. Cultures were maintained at 37°C 
under humidified conditions with 5% CO2. All procedures 
were performed on a super-clean bench (VCM-620; Dabao 
Instrument Company, Suzhou, China) and aseptic techniques 
were maintained.
Preparation of formulations  
for comparison
The aqueous suspension was prepared with pure water and 
the tincture with 70% (w/w) ethanol. The concentrations 
of Evo (0.1%, w/w) and Rut (0.1%, w/w) in the aqueous 
suspension and the tincture were identical to those in the 
microemulsion.
Cellular uptake of Evo and Rut  
in vitro
Mouse skin fibroblasts in the log phase were transferred to a 
six-well plate culture dish at 5 × 105 cells/unit. An atmosphere 
of 5% CO2 was maintained for 12 hours at 37°C. The prepared 
formulations were injected into the holes, replacing equal 
volumes of culture fluid, at 37°C in an atmosphere of 5% CO2. 
After incubation, the culture fluid was removed and the holes 
were washed three times with 1 mL of PBS and 0.5 mL of 
normal saline. The cells were then carefully scraped and 
transferred into centrifuge tubes that were placed in an ice-
water bath for ultrasonication with a ultrasonic cell disruptor 
(JY99-IIDN; LifeScientz Bio-tech Co Ltd, Ningbo, China) at 
900 w for 10 seconds. Acetic ether (200 µL) was then added 
and the mixture was shaken carefully, followed by extrac-
tion of the supernatant liquid. This process was performed 
in triplicate and the supernatant liquids were combined. The 
combined supernatant liquid was volatilized through nitro-
gen using a pressured gas-blowing concentrator (Shanghai 
ANPEL Scientific Instrument Co Ltd, Shanghai, China) in 
a draught cupboard. After the liquid dried, 100 µL methanol 
was added to dissolve the components using a vortex mixer 
(XW-80A; Shanghai Jingke Scientific Instrument Co Ltd, 
Shanghai, China), vibrated for 5 minutes, and analyzed with 
HPLC after centrifugation (5452; Eppendorf AG, Hamburg, 
Germany) at 10,000 r/minute for 5 minutes.
Cellular uptake of fluorescence-labeled 
microemulsion
Evo and Rut were replaced with rhodamine B methanol 
solution (1.0 mg/mL:10.0 mg rhodamine B dissolved in 
10 mL methanol), and the concentration of rhodamine B in 
the prepared microemulsion was 10 µg/mL. Some volume 
of culture medium in the glass culture dish (used for LSCM) 
was pipetted and replenished with an equal volume of 
rhodamine B-labeled microemulsion solution. The cells were 
then incubated in a CO2 incubator, with an atmosphere of 
5% CO2 maintained for 8 hours at 37°C. The culture fluid 
was then removed and the culture dish was washed 3 times 
with 1 mL PBS. The cells were optically scanned at different 
increments through the z-axis of an LSCM (TCS SP2; Leica 
Microsystems, Wetzlar, Germany). Optical excitations were 
performed with a 554 nm argon laser beam and fluorescence 
emission was detected at 575 nm.27
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2467
In vitro cellular uptake of evodiamine and rutaecarpineInternational Journal of Nanomedicine 2012:7
Results and discussion
Preparation and characterization  
of microemulsions
With the dropwise addition of water, the mixture underwent a 
phase transition from gel to microemulsion. The microemul-
sion was diluted to 1000 × (w/w) and the mean droplet size 
was 74 ± 7.07 nm, as measured by NanoSight (Figure 1). 
The viscosity of the microemulsion was 37.65 ± 0.14 mPa ⋅ s. 
The microemulsion showed adequate fluidity, which ensured 
free movement of the nanoparticles in the microemulsion 
fluid. The droplets were spherical and remained separate when 
observed by transmission electron microscopy (Figure 2).
Cellular uptake of Evo and Rut  
in vitro
Five concentrations of microemulsion liquid (5%, 10%, 
15%, 20%, and 30%; v/v) were evaluated in this study. The 
results showed that the amount of uptake increased with 
increases in the microemulsion concentration and began 
to taper after the microemulsion accounted for 20% of 
the culture fluid (Figure 3). Within a concentration range 
of 5%–20%, the uptake amounts for Evo and Rut were 
dose dependent, indicating that cellular uptake may occur 
via passive transport. High microemulsion concentrations 
increased the concentration of the drugs in the culture fluid, 
but an excess of microemulsion components (eg, surfactant 
and cosurfactant) may hinder cellular uptake.
As a 20% microemulsion concentration represented 
uptake saturation, the effect of incubation time on the amount 
of cellular uptake was investigated at this concentration 
(Figure 4). The amount of cellular uptake increased with the 
time from 2 to 8 hours of incubation. Uptake for both drugs 
reached a maximum at 8 hours, changed little until 12 hours, 
and then decreased slightly.
A tincture and an aqueous suspension were used as 
comparative formulations for further study. Under the same 
conditions (20% concentration of each formulation, 8 hour 
incubation time), the results (Figure 5) showed that the uptake 
amounts for the microemulsion were the smallest and those 
for the aqueous suspension were the largest. Evo and Rut are 
small molecules and highly lipid soluble. When dispersed in 
water, they are likely to be absorbed by cells. However, high 
amounts of alcohol in the tincture caused massive cellular 
necrocytosis, which resulted in a considerably lower drug 
uptake in this group, as compared with the aqueous suspen-
sion group. The mechanisms of nanoparticle-cell interaction 
are still not completely understood. dos Santos et al indicated 
that the internalization of (nano)particles was highly size 
dependent for all the cell lines studied, and that (nano)particle 
uptake may not follow the commonly defined size limits for 
uptake processes.28 Their results highlight the variability 
of uptake kinetics for one material in different cell types.28 
In general, extracellular matrix proteins have a negative 
charge, and the particles with a positive charge can adhere 
to the cell membrane. On the contrary, particles with a posi-
tive charge may weaken the adhesivity of the cell.29,30 Other 
reports31,32 have shown that nanoparticles have a positive 
surface charge that can attract and combine nonspecific static 
from the negative charges of glycoprotein, proteoglycan, and 
phospholipid on the cell surface, and that this effect depends 
on the quantity of positive charges on the surface of the 
nanoparticle and on the negatively charged macromolecules 
from the cytomembrane. For example, liposomes have a 
positive surface charge that can increase the affinity between 
nanoparticles and cells.33–35 The microemulsion with the zeta 
potential −1.02 ± 0.18 was expected to have a negative surface 
charge on the basis of the presented composition, which may 
have adversely affected the adhesivity of the cell, further 
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Figure 1 Microemulsion droplet size measured by NanoSight (NanoSight Ltd, Amesbury, UK). (A) Droplet size and relative intensity. (B) Still frame of a video of 
microemulsion droplets. 
Note: The droplets appear as bluish-green spots (taken using NanoSight).
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decreasing cellular uptake. Research has also shown that 
the incubation temperature can influence the cellular uptake 
of nanoparticles, as the uptake efficiency at 37°C is higher 
than that at 4°C, which indicates that the uptake process is 
energy dependent.36 The microemulsion used in this study 
consisted of droplets with an average size of 74 ± 7.07 nm, 
but the amount of cellular uptake was lower than that with 
the aqueous suspension. It is possible that a large distribution 
of droplet sizes hindered cellular uptake (Table 1).
Previous studies have shown that microemulsions cause 
significantly enhanced Evo and Rut permeation through 
the skin, as compared to conventional preparations such 
as tincture and aqueous suspension.10 However, in the 
current study, the in vitro uptake of Evo and Rut in mouse 
skin fibroblasts was smaller for the microemulsion than 
for the tincture and the aqueous suspension. These results 
suggest that most of the drugs loaded in a microemulsion 
are transported via intercellular spaces, while a small 
quantity of free drug may be released from the vehicle and 
ingested through transmembrane transport. In light of the 
results from previous in vivo studies,10 a possible route of 
microemulsion-enhanced percutaneous absorption is as 
follows: the microemulsion increases the fluidity of the 
bilayer and interrupts the aqueous channels in the SC, leading 
to ingestion by cells in the SC; the accumulated microemul-
sion then creates a high drug-concentration gradient, which 
causes diffusion into the dermal intercellular spaces, thereby 
enhancing transdermal drug permeation.37,38
Influence of microemulsion on cellular appearance
Various vehicles loaded with Evo and Rut affected cellular 
morphology (Figure 6). For all formulations, a concentration 
of 20% and an incubation time of 8 hours were used. 
Compared to normal cells, cells incubated with microemulsion 
(whether or not the microemulsion was loaded with drugs; 
Figures 6–8) showed no obvious changes. In addition, no 
0.5 µm
Figure 2 Transmission electron microscopy image of Evo- and Rut-loaded micro-
emulsion (stained with uranyl acetate).
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morphologic change was noted in cells incubated with the 
aqueous suspension (Figure 6). The drugs (Evo and Rut) had 
no apparent effect on the cells at the dosage used, as shown 
by the similar cellular morphology seen in cells incubated 
with the microemulsion vehicle without drugs (Figures 6–8). 
However, cells incubated with the tincture shrank sharply and 
underwent necrocytosis (Figure 6), as indicated by the amount 
of cellular debris observed floating in the culture fluid. This 
effect may have been due to the high alcohol content of the 
tincture.
In comparison with normal cellular morphology (Figure 7), 
it was found that microemulsion administration did not lead 
to transformation of the cellular morphology. Furthermore, 
the cellular morphology did not obviously transform with an 
increase in the microemulsion concentration. Pharmaceutical 
adjuncts of the prepared microemulsion, such as PEG-400 
(11.2%, w/w)39 and Cremophor EL (33.8%, w/w), are used 
extensively in the pharmaceutical industry. Cremophor EL 
use has been reported, up to the 50% level, as a solubilizer 
Figure  6  Influence  of  incubation  with  different  formulations:  (A)  tincture; 
(B) aqueous suspension; (C) microemulsion; and (D) microemulsion without Evo 
and Rut on cellular morphology.
Normal 5% 10%
15% 20% 30%
Figure 7 Influence of microemulsion concentration on cellular morphology.
2 hours4  hours 6 hours
8 hours 12 hours 24 hours
Figure 8 Influence of microemulsion incubation time on cellular morphology.
Table 1 Size distribution and droplet concentration statistics of 
microemulsion by NanoSight
Droplet size  
(nm)
Droplet concentration  
(106/mL)
Percent size 
decrease (%)
10 0 0
30 46.652 ± 1.703 0.41 ± 0.08
50 302.559 ± 116.931 14.70 ± 7.30
70 377.189 ± 25.052 53.34 ± 13.85
90 193.157 ± 49.463 82.02 ± 8.71
110 59.806 ± 24.223 91.67 ± 4.56
290 62.921 ± 31.676 100.00
in preparations of paclitaxel injections,40 and when used in 
this study, no obvious transformation of cellular morphology 
was observed with an inverted microscope. Ethyl oleate is 
extensively used in topical medications and is designated by 
the US Food and Drug Administration as harmless, which is 
supported by the results of a 91-day feeding study in rats.41 
This evidence supports the finding that the microemulsion 
has little cellular toxicity.
Cellular uptake of fluorescence-labeled 
microemulsion
Using LSCM, orange fluorescence was observed in the cyto-
plasm of mouse skin fibroblasts, clearly showing that, after 
uptake, the fluorescein was distributed in the cytoplasm of these 
cells. The fluorescence increased with the microemulsion con-
centration, as well as with incubation time (Figures 9 and 10, 
respectively). Interestingly, a variation in the amount of orange 
fluorescence was seen in accordance with the uptake amounts 
of Evo and Rut, as determined by HPLC.
The fluorescence intensity of the microemulsion group 
was relatively lower than that of the tincture and aqueous 
suspension groups (Figure 11), which may be related to the 
lowest uptake amount of rhodamine B with microemulsion as 
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the vehicle. When the lipophilic rhodamine B was loaded in 
the microemulsion, it was difficult to release and, therefore, 
difficult for cells to ingest, while the free molecules of 
rhodamine B in the aqueous suspension were easily captured. 
Cells from the tincture group showed small, diffuse, and 
indistinct fluorescence, which may be due to the fact that 
the high alcohol content led to extensive cellular death and 
rupture, resulting in the leakage of fluorochrome out of the 
cells, staining the background.
Conclusion
The amount of cellular uptake with microemulsion was 
relatively lower than with tincture and aqueous suspension, 
which may be due to the fact that most of the drug loaded in 
the microemulsion vehicle was transported via the intercel-
lular space, while a small quantity of free drug (released from 
the vehicle) was ingested through transmembrane transport. 
The prepared microemulsion was harmless to mouse skin 
fibroblasts, while tincture administration led to obvious 
cellular toxicity. This research may provide the foundation 
and inspiration for understanding the absorption mechanism 
of microemulsion as a transdermal delivery system.
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